Prognostic value of molecular markers, sub‐stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer - van Rhijn, Bas W.G.; Liu, Liyang; Vis, André N.; Bostrom, Peter J.; Zuiverloon, Tahlita C.M.; Fleshner, Neil E.; van der Aa, Madelon N.M.; Alkhateeb, Sultan S.; Bangma, Chris H.; Jewett, Michael A.S.; Zwarthoff, Ellen C.; Bapat, Bharati; et al. (BJU international, 2012)
Keywords: Aged; Biological and medical sciences; Biomarkers, Tumor - analysis; bladder; Cancer; Carcinoma, Transitional Cell - diagnosis; Classification; EORTC; Female; Gender; Hospitals; Humans; Ki-67 Antigen - analysis; Male; Medical sciences; Molecular Diagnostic Techniques; Mortality; Muscles; Mutation; Neoplasm Staging; Nephrology. Urinary tract diseases; Prognosis; Proliferating Cell Nuclear Antigen - analysis; Receptor, Fibroblast Growth Factor, Type 3 - genetics; Reviews; sub‐stage; TNM; Tumor Suppressor Protein p53 - analysis; Tumors of the urinary system; Urinary bladder; Urinary Bladder Neoplasms - diagnosis; Urinary system involvement in other diseases. Miscellaneous; Urinary tract. Prostate gland; Urine; Europe; Nephrology; Genetic marker; Molecular marker; Research; Urology; TNM; Urinary bladder; Predictive value; T1; Primary cancer; Urinary system disease; EORTC; Urinary tract disease; Malignant tumor; Risk analysis; Bladder cancer; TNM-System; sub-stage; Clinical stage; Treatment; Urinary system; bladder; Bladder disease; Cancer; European Organization for Research and Treatment of Cancer